Variant report

Variant	esv3387417
Chromosome Location	chr9:93562956-93565504
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCLAF1	chr9:93563791-93564158	GM12878	blood:	n/a	chr9:93563897-93563910 chr9:93564106-93564119 chr9:93563994-93564007
2	BHLHE40	chr9:93563964-93564164	GM12878	blood:	n/a	chr9:93564075-93564091 chr9:93564103-93564119 chr9:93564079-93564095 chr9:93564100-93564116
3	BHLHE40	chr9:93563893-93564846	K562	blood:	n/a	chr9:93563900-93563916 chr9:93564075-93564091 chr9:93564103-93564119 chr9:93564079-93564095 chr9:93564100-93564116
4	BHLHE40	chr9:93564460-93564481	GM12878	blood:	n/a	n/a
5	BRCA1	chr9:93564267-93564283	GM12878	blood:	n/a	n/a
6	CCNT2	chr9:93563783-93564596	K562	blood:	n/a	n/a
7	CHD1	chr9:93564204-93565045	GM12878	blood:	n/a	n/a
8	CHD1	chr9:93563902-93564658	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr9:93564260-93564291	GM12878	blood:	n/a	n/a
10	CHD2	chr9:93564155-93564657	K562	blood:	n/a	n/a
11	CTBP2	chr9:93563441-93564584	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr9:93563949-93564013	GM19238	blood:	n/a	n/a
13	CTCF	chr9:93563603-93563626	GM19238	blood:	n/a	n/a
14	CTCF	chr9:93564100-93564250	GM12873	blood:	n/a	n/a
15	CTCF	chr9:93563660-93563810	GM12864	blood:	n/a	n/a
16	CTCF	chr9:93563800-93563950	SAEC	small airway:	n/a	n/a
17	CTCF	chr9:93563500-93563650	GM12864	blood:	n/a	n/a
18	CTCF	chr9:93563914-93563923	MCF-7	breast:	n/a	n/a
19	CTCF	chr9:93563560-93563710	GM12873	blood:	n/a	n/a
20	CTCF	chr9:93563600-93563750	GM12864	blood:	n/a	n/a
21	CTCF	chr9:93563560-93563710	WERI-Rb-1	eye:	n/a	n/a
22	CTCF	chr9:93563640-93563790	GM12872	blood:	n/a	n/a
23	CTCF	chr9:93563924-93563958	MCF-7	breast:	n/a	n/a
24	CTCF	chr9:93563480-93563630	GM12873	blood:	n/a	n/a
25	CTCF	chr9:93563720-93563870	GM12874	blood:	n/a	n/a
26	CTCF	chr9:93563480-93563630	HEK293	kidney:	n/a	n/a
27	CTCF	chr9:93563902-93563912	MCF-7	breast:	n/a	n/a
28	CTCF	chr9:93563953-93564089	Spleen_OC	spleen:	n/a	n/a
29	CTCF	chr9:93563840-93563990	GM12866	blood:	n/a	n/a
30	CTCF	chr9:93563680-93563830	GM12878	blood:	n/a	n/a
31	CTCF	chr9:93563888-93563898	MCF-7	breast:	n/a	n/a
32	CTCF	chr9:93563930-93564013	GM12878	blood:	n/a	n/a
33	CTCF	chr9:93563480-93563630	GM12871	blood:	n/a	n/a
34	CUX1	chr9:93563648-93563843	GM12878	blood:	n/a	n/a
35	E2F4	chr9:93563808-93564129	MCF10A-Er-Src	breast:	n/a	chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
36	E2F6	chr9:93563751-93564207	K562	blood:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
37	E2F6	chr9:93563712-93564118	A549	lung:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
38	E2F6	chr9:93563456-93564537	H1-hESC	embryonic stem cell:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
39	E2F6	chr9:93563872-93564074	A549	lung:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93563998-93564007
40	E2F6	chr9:93564383-93564539	K562	blood:	n/a	n/a
41	E2F6	chr9:93563594-93564640	K562	blood:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
42	E2F6	chr9:93563796-93564128	K562	blood:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
43	E2F6	chr9:93563744-93564476	H1-hESC	embryonic stem cell:	n/a	chr9:93563947-93563958 chr9:93563899-93563909 chr9:93564104-93564114 chr9:93563998-93564007 chr9:93564107-93564117
44	EBF1	chr9:93563860-93564178	GM12878	blood:	n/a	n/a
45	EBF1	chr9:93564279-93564626	GM12878	blood:	n/a	chr9:93564462-93564473 chr9:93564464-93564473
46	EBF1	chr9:93564131-93564674	GM12878	blood:	n/a	chr9:93564462-93564473 chr9:93564464-93564473
47	EBF1	chr9:93563514-93563805	GM12878	blood:	n/a	chr9:93563672-93563681
48	ELF1	chr9:93563731-93564208	K562	blood:	n/a	chr9:93564064-93564077 chr9:93564103-93564112
49	ELF1	chr9:93563783-93564354	MCF-7	breast:	n/a	chr9:93564064-93564077 chr9:93564103-93564112
50	ELF1	chr9:93563507-93564597	GM12878	blood:	n/a	chr9:93564064-93564077 chr9:93564373-93564385 chr9:93564103-93564112

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:93563776-93563826	HepG2	liver:	n/a
2	chr9:93563776-93563826	HepG2	liver:	n/a
3	chr9:93564149-93564199	A549	lung:	n/a
4	chr9:93564456-93564506	HNPCEpiC	eye:	n/a
5	chr9:93564028-93564078	GM12892	blood:	n/a
6	chr9:93564028-93564078	ECC-1	luminal epithelium:	n/a
7	chr9:93564028-93564078	A549	lung:	n/a
8	chr9:93564456-93564506	AG10803	skin:	n/a
9	chr9:93564339-93564389	AG09319	gingival:	n/a
10	chr9:93563776-93563826	NHDF-neo	bronchial:	n/a
11	chr9:93564456-93564506	LNCaP	prostate:	n/a
12	chr9:93564456-93564506	AG04450	lung:	fetal
13	chr9:93564028-93564078	BE2_C	brain:	n/a
14	chr9:93563778-93563828	PANC-1	pancreas:	n/a
15	chr9:93563776-93563826	HUVEC	blood vessel:	n/a
16	chr9:93563776-93563826	AG10803	skin:	n/a
17	chr9:93563776-93563826	Hela-S3	cervix:	n/a
18	chr9:93563776-93563826	RPTEC	kidney:	n/a
19	chr9:93563776-93563826	AG09309	skin:	n/a
20	chr9:93563776-93563826	AG04449	skin:	fetal
21	chr9:93564149-93564199	ProgFib	skin:	n/a
22	chr9:93564456-93564506	GM19239	blood:	n/a
23	chr9:93563778-93563828	NB4	blood:	n/a
24	chr9:93563778-93563828	HCM	heart:	n/a
25	chr9:93563776-93563826	SAEC	small airway:	n/a
26	chr9:93564603-93564653	HCPEpiC	choroid plexus:	n/a
27	chr9:93564149-93564199	RPTEC	kidney:	n/a
28	chr9:93564028-93564078	K562	blood:	n/a
29	chr9:93564603-93564653	MCF-7	breast:	n/a
30	chr9:93564603-93564653	PANC-1	pancreas:	n/a
31	chr9:93563776-93563826	GM12878	blood:	n/a
32	chr9:93564339-93564389	U87	brain:	n/a
33	chr9:93563778-93563828	SK-N-MC	brain:	n/a
34	chr9:93563778-93563828	NHBE	bronchial:	n/a
35	chr9:93563778-93563828	HCF	heart:	n/a
36	chr9:93564028-93564078	HRPEpiC	eye:	n/a
37	chr9:93564603-93564653	NHBE	bronchial:	n/a
38	chr9:93564603-93564653	SK-N-SH_RA	brain:	n/a
39	chr9:93563778-93563828	HL-60	blood:	n/a
40	chr9:93564339-93564389	HCF	heart:	n/a
41	chr9:93564149-93564199	Hela-S3	cervix:	n/a
42	chr9:93564339-93564389	Hela-S3	cervix:	n/a
43	chr9:93564603-93564653	IMR90	lung:	fetal
44	chr9:93564149-93564199	H1-hESC	embryonic stem cell:	embryo
45	chr9:93564149-93564199	Jurkat	blood:	n/a
46	chr9:93564603-93564653	SK-N-MC	brain:	n/a
47	chr9:93563778-93563828	HRCEpiC	kidney:	n/a
48	chr9:93564456-93564506	GM12878	blood:	n/a
49	chr9:93563778-93563828	AG10803	skin:	n/a
50	chr9:93563778-93563828	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr9:93564315..93567256-chr9:93578660..93580228,2	MCF-7	breast:
2	chr9:93561901..93563996-chr9:93577117..93579715,2	MCF-7	breast:
3	chr9:93557618..93560728-chr9:93560879..93563311,3	K562	blood:

Variant related genes	Relation type
SYK	TF binding region
SYK	CpG island

Extended variants
information (count: 119 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:119 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560624405	chr9:93562968-93562969	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs138937001	chr9:93562969-93562970	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs188987828	chr9:93562972-93562973	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs566248693	chr9:93563004-93563005	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs535299645	chr9:93563035-93563036	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs551701129	chr9:93563053-93563054	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs75674673	chr9:93563060-93563061	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs537620881	chr9:93563260-93563261	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs557536849	chr9:93563261-93563262	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs201421001	chr9:93563265-93563266	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs79522325	chr9:93563266-93563267	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs290987	chr9:93563267-93563268	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs562460767	chr9:93563310-93563311	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs149435592	chr9:93563326-93563327	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs192612437	chr9:93563352-93563353	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs545254225	chr9:93563364-93563365	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs147449482	chr9:93563379-93563380	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs575122566	chr9:93563396-93563397	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs543996216	chr9:93563398-93563399	Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs112828081	chr9:93563420-93563421	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs560687806	chr9:93563454-93563455	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs562674457	chr9:93563459-93563460	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs145051789	chr9:93563460-93563461	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs529752475	chr9:93563469-93563470	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs139873190	chr9:93563504-93563505	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs290986	chr9:93563536-93563537	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	disease
27	rs568270005	chr9:93563611-93563612	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs184320278	chr9:93563750-93563751	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs571967505	chr9:93563784-93563785	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs544858324	chr9:93563791-93563792	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs145404195	chr9:93563793-93563794	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs1155281	chr9:93563830-93563831	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs567765845	chr9:93563841-93563842	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs3748188	chr9:93563855-93563856	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs372016172	chr9:93563862-93563863	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs372425043	chr9:93563880-93563881	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs34221447	chr9:93563884-93563885	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs147269263	chr9:93563908-93563909	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs370025832	chr9:93563916-93563917	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs558468039	chr9:93563967-93563968	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs3748189	chr9:93563973-93563974	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs375748262	chr9:93563986-93563987	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs544009901	chr9:93563990-93563991	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs554316986	chr9:93563991-93563992	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs2562397	chr9:93563992-93563993	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs530677450	chr9:93563995-93563996	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs199721697	chr9:93564080-93564081	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs559972805	chr9:93564084-93564085	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs200712879	chr9:93564088-93564089	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs532179588	chr9:93564100-93564101	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Medulloblastoma	21979893	CNVD
microdeletion syndrome	16199537	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Leukemia	18688285	CNVD
Non-small cell lung cancer	21044232	CNVD
Brain cancer	20823417	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Renal cell carcinoma	19461508	CNVD
Neuroblastoma	18923191	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Heart disease	21282601	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Lung cancer	18438408	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	21251322	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	17603634	CNVD
Acute myeloid leukemia	20729466	CNVD
Oral cancer	21386901	CNVD
Bipolar disorder	18458673	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Gastric cancer	17908304	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Biliary cancer	19435499	CNVD
small cell lung cancer	20016488	CNVD
Intracranial aneurysm	16715129	CNVD
Cardiac fibroma	18329553	CNVD
Mental retardation	21693067	CNVD
Glioma	17123091	CNVD
Mantle cell lymphoma	19029149	CNVD
Breast cancer	17133270	CNVD
Basal cell nevus syndrome	21572526	CNVD
Mental retardation	19951919	CNVD
Retinoblastoma	22278416	CNVD
9q22.3 microdeletion syndrome	22283845	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:93551800-93563400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr9:93552000-93563400	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
3	chr9:93556000-93563400	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr9:93557600-93563400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr9:93557600-93563400	Weak transcription	Duodenum Mucosa	Duodenum
6	chr9:93557600-93563400	Weak transcription	Pancreas	Pancrea
7	chr9:93559000-93563800	Weak transcription	Gastric	stomach
8	chr9:93559200-93563200	Weak transcription	Thymus	Thymus
9	chr9:93559400-93563200	Weak transcription	Stomach Mucosa	stomach
10	chr9:93561200-93564000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
11	chr9:93561400-93563200	Enhancers	Primary B cells from cord blood	blood
12	chr9:93561800-93563400	Enhancers	Primary B cells from peripheral blood	blood
13	chr9:93561800-93563400	Enhancers	GM12878-XiMat	blood
14	chr9:93562400-93563200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr9:93562600-93563000	Enhancers	Primary neutrophils fromperipheralblood	blood
16	chr9:93562600-93563200	Enhancers	Primary hematopoietic stem cells	blood
17	chr9:93562600-93563200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr9:93562800-93563400	Enhancers	Primary hematopoietic stem cells short term culture	blood
19	chr9:93562800-93563400	Enhancers	Fetal Intestine Large	intestine
20	chr9:93562800-93563400	Enhancers	Fetal Thymus	thymus
21	chr9:93562800-93563400	Enhancers	Rectal Mucosa Donor 29	rectum
22	chr9:93562800-93563400	Enhancers	Rectal Mucosa Donor 31	rectum
23	chr9:93562800-93563400	Enhancers	K562	blood
24	chr9:93562800-93563800	Enhancers	Spleen	Spleen
25	chr9:93563000-93563800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
26	chr9:93563000-93563800	Bivalent Enhancer	Brain Hippocampus Middle	brain
27	chr9:93563200-93563400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
28	chr9:93563200-93563400	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
29	chr9:93563200-93563400	Enhancers	Fetal Intestine Small	intestine
30	chr9:93563200-93563400	Enhancers	Fetal Kidney	kidney
31	chr9:93563200-93563400	Bivalent Enhancer	Fetal Lung	lung
32	chr9:93563200-93563400	Enhancers	Stomach Mucosa	stomach
33	chr9:93563200-93563400	Enhancers	Thymus	Thymus
34	chr9:93563200-93563600	Bivalent Enhancer	Brain Germinal Matrix	brain
35	chr9:93563200-93563800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr9:93563200-93564000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr9:93563200-93564600	Flanking Active TSS	Primary B cells from cord blood	blood
38	chr9:93563200-93568000	Flanking Active TSS	Primary hematopoietic stem cells	blood
39	chr9:93563400-93563600	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr9:93563400-93563600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr9:93563400-93563600	Flanking Active TSS	H9 Cell Line	embryonic stem cell
42	chr9:93563400-93563600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
43	chr9:93563400-93563600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
44	chr9:93563400-93563600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
45	chr9:93563400-93563600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr9:93563400-93563600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr9:93563400-93563600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
48	chr9:93563400-93563600	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr9:93563400-93563600	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr9:93563400-93563600	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links